Headquarters
807 WENDEL STREET, HOUSTON, TX 77009-7431, US
HOUSTON, TX, US
AURAVAX THERAPEUTICS, INC.
From the company
AuraVax Therapeutics, Inc. is commercializing its intranasal platform called NanoSTING to treat and prevent respiratory infections independent of the pathogen. NanoSTING technology activates the STING pathway to restore and boost innate immunity. The company is developing its technology as a new class of host-directed-therapeutics to treat infections from respiratory pathogens, and is also pursuing NanoSTING to improve intranasal vaccines.
Products & services offered
Capabilities 3
Materials 1
Classifications
- Materials (1)
- nano particles
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.